FDA Approved: TECHNETIUM TC 99M SESTAMIBI — Supplemental Application (Curium US LLC)

View source ↗

Summary

FDA approved a supplemental application for Technetium Tc-99m Sestamibi (Curium US LLC), updating its approval-related labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Technetium Tc-99m Sestamibi (Technetium Tc-99m Sestamibi)

Snippet

SUPPL AP for TECHNETIUM TC 99M SESTAMIBI (TECHNETIUM TC 99M SESTAMIBI)